Literature DB >> 16624367

Influenza virus inhibits RNA polymerase II elongation.

Annie Y Chan1, Frank T Vreede, Matt Smith, Othmar G Engelhardt, Ervin Fodor.   

Abstract

The influenza virus RNA-dependent RNA polymerase interacts with the serine-5 phosphorylated carboxy-terminal domain (CTD) of the large subunit of RNA polymerase II (Pol II). It was proposed that this interaction allows the viral RNA polymerase to gain access to host mRNA-derived capped RNA fragments required as primers for the initiation of viral mRNA synthesis. Here, we show, using a chromatin immunoprecipitation (ChIP) analysis, that similar amounts of Pol II associate with Pol II promoter DNAs in influenza virus-infected and mock-infected cells. However, there is a statistically significant reduction in Pol II densities in the coding region of Pol II genes in infected cells. Thus, influenza virus specifically interferes with Pol II elongation, but not Pol II initiation. We propose that influenza virus RNA polymerase, by binding to the CTD of initiating Pol II and subsequent cleavage of the capped 5' end of the nascent transcript, triggers premature Pol II termination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624367     DOI: 10.1016/j.virol.2006.03.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication.

Authors:  Tsai-Ling Liao; Chung-Yi Wu; Wen-Chi Su; King-Song Jeng; Michael M C Lai
Journal:  EMBO J       Date:  2010-10-05       Impact factor: 11.598

2.  Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network.

Authors:  Lionel Tafforeau; Thibault Chantier; Fabrine Pradezynski; Johann Pellet; Philippe E Mangeot; Pierre-Olivier Vidalain; Patrice Andre; Chantal Rabourdin-Combe; Vincent Lotteau
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

3.  Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.

Authors:  Kevin M Coombs; Alicia Berard; Wanhong Xu; Oleg Krokhin; Xiaobo Meng; John P Cortens; Darwyn Kobasa; John Wilkins; Earl G Brown
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

Review 4.  The role of the influenza virus RNA polymerase in host shut-off.

Authors:  Frank T Vreede; Ervin Fodor
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

5.  A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.

Authors:  Wen-Chi Su; Shih-Feng Hsu; Yi-Yuan Lee; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

6.  Regulation of influenza RNA polymerase activity and the switch between replication and transcription by the concentrations of the vRNA 5' end, the cap source, and the polymerase.

Authors:  Andrew C Olson; Eric Rosenblum; Robert D Kuchta
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

7.  De novo replication of the influenza virus RNA genome is regulated by DNA replicative helicase, MCM.

Authors:  Atsushi Kawaguchi; Kyosuke Nagata
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

8.  Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II.

Authors:  A Rodriguez; A Pérez-González; A Nieto
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

9.  Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus.

Authors:  Yong Liu; Kun Qin; Geng Meng; Jinfang Zhang; Jianfang Zhou; Guangyu Zhao; Ming Luo; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2013-02-22       Impact factor: 5.157

10.  An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis.

Authors:  Tadasuke Naito; Yoshihiko Kiyasu; Kenji Sugiyama; Ayumi Kimura; Ryosuke Nakano; Akio Matsukage; Kyosuke Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.